GlassScriptPhysician profile
Paul Jeong Kim
NPI 1013971027
$927,873.28
in general payments reported to CMS, 2019-2025
19 companies · $236K in 2025
The $236K reported for 2025 was more than what 99% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $123K · 2020: $105K · 2021: $113K · 2022: $125K · 2023: $67K · 2024: $161K · 2025: $236K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $278K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $146K · Travel and Lodging: $30K · Food and Beverage: $9,463.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $277,915.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $145,775.00 |
| Travel and Lodging | $29,981.92 |
| Food and Beverage | $9,463.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $464,508.70 | 2019-2023 | V.A.C. Veraflo, Prevena, V.A.C. Veraflo Cleanse Choice |
| Polynovo North America LLC | $220,284.43 | 2023-2025 | Novosorb Btm |
| Solventum Corporation | $111,355.62 | 2024-2025 | Prevena, 3m Cavilon, V.A.C. Veraflo |
| Smith+Nephew, INC. | $48,199.37 | 2019-2025 | Renasys Touch, Allevyn Life L 15.4x15.4 Ctn10, Na |
| Urgo Medical North America, LLC | $29,728.40 | 2020-2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Integra Lifesciences Corporation | $20,469.97 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Medline Industries LP | $12,729.60 | 2019-2020 | |
| Mimedx Group, INC. | $12,203.58 | 2024-2025 | Bovine Collagen |
| Polarityte, INC. | $5,241.20 | 2019-2021 | |
| Next Science LLC | $1,600.00 | 2019 | |
| Grt US Holding, INC. | $836.76 | 2021-2022 | |
| Stryker Corporation | $161.30 | 2022 | |
| Novastep INC. | $146.71 | 2025 | Nexis |
| Access Pro Medical, LLC | $129.98 | 2025 | Matriderm |
| Acumed LLC | $121.42 | 2022-2024 | Acumed |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Advanced Oxygen Therapy INC. | $83.00 | 2019 | |
| Si-Bone, INC. | $34.18 | 2019 | |
| Bsn Medical INC | $21.74 | 2024 | |
| Nestle Healthcare Nutrition INC. | $17.32 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.